Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ), the HI-STEM institute, and the Broad Institute have demonstrated that ...

A new stem cell–based therapy challenges traditional pain treatment by using pain-sensing neurons to reduce inflammation and protect joints. Newly released preclinical data describes an unconventional ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

When we think of healthcare, certain images come to mind: nurses at the bedside, doctors making diagnoses, or a surgeon in ...

Do infrared saunas really work? Experts explain the benefits and risks, plus our honest review of the BON CHARGE sauna dome.

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

Today, nearly all patients with septic shock receive the same first-line therapy. However, early research suggests that some ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

We considered more than 65 different online therapy services and platforms while creating the very best text-based therapy ...

The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...